Biomet expects to use the net proceeds of this offering to fund its tender offer for any and all of its outstanding 10⅜ / 11⅛ percent senior toggle notes due 2017, including related fees and expenses, and to purchase, redeem, defease or otherwise acquire or retire its outstanding indebtedness.
More Articles on Orthopedic Devices:
7 Biggest Factors Impacting Spine Research & Innovation
Wright Medical Group Slapped With Subpoena for Hip Device Documents
Alphatec Spine Reports 2Q Revenue of $48.2M, Down 5.2%
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
